naion and glp 1 Newest Study of Semaglutide Finds No Increased Risk glp-1 naion Anterior ischemic optic

it depends on your age and comfort level

PMID 1740285.PMC 1373872 Allen AL (2003)

Cell viability and cell proliferation curve experiment Cell viability was assessed using a CCK-8 assay (Cat: A311-01

The DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial specifically included patients with chronic kidney disease with or without diabetes to receive dapagliflozin and found that these patients experienced a lower risk of ESRD, GFR decline of at least 50%, or death from renal or cardiovascular causes in comparison to placebo [31]

Individual Variability Responses may vary based on factors like injury type, metabolic health, and overall physiology